Quince Therapeutics (QNCX) Change in Cash (2018 - 2026)
Quince Therapeutics (QNCX) posted quarterly Change in Cash of $12.4 million for Q1 2026, up 692.43% year-over-year from $1.6 million in Q1 2025, and up 2021.31% quarter-over-quarter from -$643000.0 in Q4 2025.
Quince Therapeutics (QNCX) Change in Cash (2018 - 2026) Analysis & Trends
Quince Therapeutics' Change in Cash history runs 9 years deep, the most recent figure standing at $12.4 million for Q1 2026.
- In Q1 2026, Change in Cash rose 692.43% year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $10.4 million (up 174.01% YoY), while the FY2025 annual figure was -$403000.0, up 97.23% from the prior year.
- Change in Cash for Q1 2026 stood at $12.4 million, up from -$643000.0 in the prior quarter.
- The five-year high for Change in Cash was $12.8 million in Q4 2022, with the low at -$24.1 million in Q2 2023.
- The 5-year median for Change in Cash is -$880000.0 (2023), against an average of -$3.0 million.
- The sharpest annual moves came in 2024 and 2026: Change in Cash slumped 412.28% in 2024, then surged 692.43% in 2026.
- Quince Therapeutics' Change in Cash stood at $12.8 million in 2022, then tumbled by 106.89% to -$880000.0 in 2023, then jumped by 501.93% to $3.5 million in 2024, then tumbled by 118.18% to -$643000.0 in 2025, then soared by 2021.31% to $12.4 million in 2026.
- Business Quant data shows QNCX's Change in Cash at $12.4 million in Q1 2026, -$643000.0 in Q4 2025, and -$10.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Quince Therapeutics | 203.43 Mn | 203.43 Mn | - | 97.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.35 Mn |
| Dec 31, 2025 | -643,000.00 |
| Sep 30, 2025 | -10.37 Mn |
| Jun 30, 2025 | 9.06 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | -5.22 Mn |
| Jun 30, 2024 | -13.92 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | -880,000.00 |
| Sep 30, 2023 | -1.02 Mn |
| Jun 30, 2023 | -24.06 Mn |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 12.77 Mn |
| Sep 30, 2022 | -15.12 Mn |
| Jun 30, 2022 | -20.64 Mn |
| Mar 31, 2022 | -2.16 Mn |
| Dec 31, 2021 | 7.52 Mn |
| Sep 30, 2021 | -11.84 Mn |
| Jun 30, 2021 | -11.27 Mn |